Showing results (51-60 of 1,748) with videos related to
Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2004
Humanization of antagonistic anti-human 4-1BB monoclonal antibody using a phage-displayed combinatorial libraryUnn Hwa Lee, Ji Hee Son, Jeong Jin Lee, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2004
Ex vivo evaluation of anti-EpCAM immunocytokine huKS-IL2 in ovarian cancerJoseph P Connor, Mildred Felder, Jacquelyn Hank, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2004
Phase I trial of antigen-specific gene therapy using a recombinant vaccinia virus encoding MUC-1 and IL-2 in MUC-1-positive patients with advanced prostate cancerAllan J Pantuck, Arndt van Ophoven, Barbara J Gitlitz, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2005
Evidence that IL-13R alpha2 chain in human glioma cells is responsible for the antitumor activity mediated by receptor-directed cytotoxin therapyKoji Kawakami, Mitomu Kioi, Qi Liu, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2005
Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regressionJianping Huang, Hung T Khong, Mark E Dudley, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 23, 2005
Transcutaneous immunization with cytotoxic T-cell peptide epitopes provides effective antitumor immunity in miceTsuyoshi Itoh, Esteban CelisJournal of Immunotherapy (Hagerstown, Md. : 1997)|August 23, 2005
Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigensBela Denes, Valentina Krausova, Nadja Fodor, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 23, 2005
Tumor vaccination by Salmonella typhimurium after transformation with a eukaryotic expression vector in mice: impact of a Salmonella typhimurium gene interfering with MHC class I presentationSusanne Hummel, Ron N Apte, Udi Qimron, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 23, 2005
Th1-polarizing capacity of clinical-grade dendritic cells is triggered by Ribomunyl but is compromised by PGE2: the importance of maturation cocktailsWim Jongmans, Dorien M Tiemessen, Iris J H van Vlodrop, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 23, 2005
Histologic predictors of renal cell carcinoma response to interleukin-2-based therapyMelissa P Upton, Robert A Parker, Amanda Youmans, et al.Pageof 175